Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”

Marc‐Oliver Grimm, Antoine G. van der Heijden, Marc Colombel, Tim Muilwijk, Luis Martínez‐Piñeiro, Marko Babjuk, Levent N. Türkeri, Joan Palou, Anup Patel, Anders Bjartell, Christien Caris, Raymond G. Schipper, Wim P.J. Witjes, Jörg Horstmann, S. Machtens, E. Mumperow, Andreas Al Ghazal, Thomas Pulte, Michael Stephan-Odenthal, Georgios Gakis, Mario W. Kramer, Marc‐Oliver Grimm, Dirk Zaak, Bernd J. Schmitz‐Dräger, Holger Schreier, Jan Lehmann, T. Werner, Jörg Klier, Jan Marin, Wolfgang Rulf, Eva Hellmis, Andreas Schneider, Spiegelhalder, Manfred P. Wirth, Theodor Klotz, H. Suttmann, Michael Siebels, Gerd Rodemer, Robert H. Rudolph, Roger Zillmann, Marie L. De Bruin, Sarah Bos, R. van Moorselaar, T. De Reijke, Joost L. Boormans, Bart P. Wijsman, Harm H.E. van Melick, E. Boven, Richard P. Meijer, Antoine G. van der Heijden, H. Vergunst, E. te Slaa, Anna M. Leliveld, Marc Colombel, A. Ruffion, Christian Pfister, Morgan Rouprêt, Jacques Irani, Gabriel Stoica, Siska Van Bruwaene, Filip Ameye, H.C. Arentsen, Steven Joniau, Pastora Beardo